Cimpress plc
NASDAQ:CMPRAdvertising Agencies
+$1.23 today
- Market cap
- $1.37B
- Beta
- 1.80
- P/E (TTM)
- 45.8
- EPS (TTM)
- $1.88
Volume 0.24M
Average 0.18M
CMPR Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Cimpress plcNASDAQ: CMPR
Research & Development · Q3 FY2026 · quarter ended Mar 2026
Research & development grows in line with its trailing trend
Q3 FY2026 research & development of $86.89M rose 4.5% year over year, in line with the +4.6% change in trailing-twelve-month research & development. Sequentially, it fell 2.5% from the prior quarter. Over 3 fiscal years it compounded at +4.5% a year.
Context
- Research & development amounted to 9.8% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +4.5% toward the trailing-twelve-month pace of +4.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 334.04M USD
- Year-over-year change
- +3.7%
- 4-year CAGR
- +7.2%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 334.04M | +3.7% |
| FY2024 | 2024-06-30 | 321.97M | +6.5% |
| FY2023 | 2023-06-30 | 302.26M | +3.2% |
| FY2022 | 2022-06-30 | 292.85M | +15.7% |
| FY2021 | 2021-06-30 | 253.06M | — |
Research & Development vs competitors
How CMPR compares with its peers on the latest reported figures
- CMPR's LTM Mar 2026 research & development of $347.04M is the highest of the 5 companies compared; the peer median is $0.
- Its year-over-year change of +4.6% is the highest of 2, against a peer median of -3.0%.
- Research & development amounts to 9.5% of revenue for CMPR, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $347.04M | +4.6% | +4.5% | 9.5% | |
| LTM Mar 2026 | $32M | -3.0% | -1.0% | 2.9% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Feb 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CMPR) | $0 | -3.0% | -1.0% | 0.0% | |
Competitors are the stored peer set for CMPR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 2.58B | 2.89B | 3.08B | 3.29B | 3.4B |
| Cost of Revenue | 1.3B | 1.49B | 1.64B | 1.7B | 1.79B |
| Gross Profit | 1.28B | 1.39B | 1.44B | 1.6B | 1.62B |
| Gross Margin | 49.5% | 48.3% | 46.7% | 48.5% | 47.5% |
| Research & Development | 253.06M | 292.85M | 302.26M | 321.97M | 334.04M |
| Selling, General & Admin | 822.98M | 985.7M | 983.22M | 995.61M | 1.03B |
| Operating Expenses | 1.15B | 1.35B | 1.38B | 1.35B | 1.39B |
| Depreciation & Amortization | 173.21M | 175.68M | 162.43M | 151.76M | 141.13M |
| EBITDA | 229.03M | 284.44M | 245M | 400.03M | 353.32M |
| EBITDA Margin | 8.9% | 9.9% | 8.0% | 12.2% | 10.4% |
| Operating Income | 123.51M | 47.3M | 57.31M | 247.35M | 226.27M |
| Operating Margin | 4.8% | 1.6% | 1.9% | 7.5% | 6.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 119.37M | 99.43M | 112.79M | 119.82M | 115.23M |
| Other Income / Expenses | (187.06M) | (37.97M) | (87.53M) | (118.91M) | (129.31M) |
| Income Before Tax | (63.55M) | 9.33M | (30.22M) | 128.45M | 96.96M |
| Pre-Tax Margin | -2.5% | 0.3% | -1.0% | 3.9% | 2.8% |
| Income Tax Expense | 18.9M | 59.9M | 155.49M | (49.36M) | 84.11M |
| Net Income | (85.23M) | (54.33M) | (185.98M) | 173.68M | 14.95M |
| Net Margin | -3.3% | -1.9% | -6.0% | 5.3% | 0.4% |
| EPS (Basic) | (3.28) | (2.08) | (7.08) | 6.64 | 0.60 |
| EPS (Diluted) | (3.28) | (2.08) | (7.08) | 6.43 | 0.58 |
| Weighted Avg Shares | 26M | 26.09M | 26.25M | 27.01M | 25.78M |
| Weighted Avg Shares (Diluted) | 26M | 26.09M | 26.25M | 27M | 25.64M |
Cimpress plc
NASDAQ:CMPR
Intrinsic Alpha fair value
Locked
Current Price
$55.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.